S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)

Aptevo Therapeutics (APVO) Institutional Ownership

$0.16
-0.01 (-5.75%)
(As of 03/1/2024 ET)

Institutional Ownership Changes (13F Filings) for Aptevo Therapeutics (NASDAQ:APVO)

Current
Institutional Ownership
Percentage
8.06%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$979,398.33
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$21,367.50
Get APVO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aptevo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

APVO Institutional Buying and Selling by Quarter


Aptevo Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2024Citadel Advisors LLC262,124$47K0.0%N/A1.391%
11/15/2023Sabby Management LLC1,334,169$0.44M0.3%N/A11.581%
11/15/2023Armistice Capital LLC1,235,000$0.41M0.0%N/A10.717%
8/15/2023Cantor Fitzgerald L. P.251,122$0.37M0.0%+14.8%3.331%
8/11/2023Renaissance Technologies LLC80,186$0.12M0.0%+45.8%1.063%
5/12/2023Renaissance Technologies LLC54,986$0.11M0.0%-16.0%0.759%
2/15/2023Morgan Stanley11,313$26K0.0%-39.9%0.222%
2/9/2023Dimensional Fund Advisors LP12,705$29K0.0%N/A0.250%
2/1/2023Bank of Montreal Can10,000$61K0.0%N/A0.196%
11/15/2022Cantor Fitzgerald L. P.133,700$0.41M0.0%N/A2.627%
11/15/2022Citadel Advisors LLC16,776$51K0.0%N/A0.330%
11/7/2022Virtu Financial LLC28,421$86K0.0%+122.6%0.558%
8/13/2022Virtu Financial LLC12,768$46K0.0%N/A0.255%
8/13/2022Renaissance Technologies LLC69,886$0.25M0.0%+18.7%1.396%
8/12/2022Franklin Resources Inc.10,788$39K0.0%-32.2%0.215%
5/13/2022Renaissance Technologies LLC58,886$0.35M0.0%-14.3%1.176%
5/13/2022Northern Trust Corp16,695$98K0.0%-26.0%0.333%
5/13/2022Vanguard Group Inc.240,819$1.41M0.0%+7.3%4.807%
5/11/2022Bank of New York Mellon Corp25,952$0.15M0.0%N/A0.518%
12/10/2021Towercrest Capital Management211,227$3.26M0.6%N/A4.313%
12/8/2021Moors & Cabot Inc.389,269$3.73M0.2%N/A7.948%
11/15/2021Franklin Resources Inc.15,650$0.24M0.0%N/A0.320%
11/15/2021GSA Capital Partners LLP13,651$0.21M0.0%N/A0.279%
11/12/2021Renaissance Technologies LLC143,419$2.21M0.0%-10.3%2.931%
11/9/2021BlackRock Inc.55,394$0.86M0.0%+1.9%1.133%
11/5/2021Moors & Cabot Inc.389,269$3.73M0.3%N/A7.954%
8/17/2021Balyasny Asset Management LLC18,012$0.40M0.0%-70.6%0.405%
8/17/2021Boothbay Fund Management LLC15,350$0.34M0.0%+4.9%0.345%
8/16/2021Alyeska Investment Group L.P.139,172$3.12M0.0%-80.9%3.127%
8/16/2021Morgan Stanley8,364$0.19M0.0%+163.4%0.188%
8/16/2021Kennedy Capital Management Inc.187,995$4.22M0.1%N/A4.225%
8/16/2021State Street Corp10,973$0.25M0.0%N/A0.247%
8/13/2021Renaissance Technologies LLC159,923$3.59M0.0%-23.6%3.594%
8/13/2021Anson Funds Management LP35,587$0.80M0.1%-26.6%0.800%
8/13/2021Northern Trust Corp22,652$0.51M0.0%+170.7%0.509%
8/13/2021QS Investors LLC15,650$0.35M0.0%+37.3%0.352%
8/13/2021Geode Capital Management LLC38,917$0.87M0.0%+8.8%0.875%
8/13/2021Vanguard Group Inc.134,760$3.02M0.0%+2.9%3.028%
5/17/2021Schonfeld Strategic Advisors LLC9,700$0.30M0.0%-12.6%0.218%
5/14/2021RTW Investments LP281,402$8.59M0.1%-2.4%6.324%
5/14/2021Dynamic Technology Lab Private Ltd14,022$0.43M0.0%+6.2%0.315%
5/13/2021QS Investors LLC11,400$0.35M0.0%N/A0.256%
5/13/2021JBF Capital Inc.3,907$0.12M0.0%+49.9%0.088%
5/13/2021Renaissance Technologies LLC209,223$6.39M0.0%-17.8%4.702%
5/13/2021Bank of New York Mellon Corp9,964$0.31M0.0%N/A0.224%
5/13/2021Bank of Montreal Can25,280$0.67M0.0%-20.1%0.568%
5/12/2021Geode Capital Management LLC35,762$1.09M0.0%+26.8%0.804%
5/7/2021BlackRock Inc.57,605$1.76M0.0%-1.0%1.294%
3/8/2021Dimensional Fund Advisors LP5,502$0.20M0.0%N/A0.126%
2/25/2021Dimensional Fund Advisors LP5,502$0.20M0.0%N/A0.126%
2/24/2021Alyeska Investment Group L.P.49,601$1.82M0.0%N/A1.133%
2/18/2021Ghost Tree Capital LLC50,000$1.83M0.4%N/A1.142%
2/16/2021Alyeska Investment Group L.P.49,601$1.82M0.0%N/A1.133%
2/16/2021Pura Vida Investments LLC8,203$0.30M0.0%N/A0.187%
2/16/2021Price T Rowe Associates Inc. MD6,300$0.23M0.0%N/A0.144%
2/12/2021Stonepine Capital Management LLC18,280$0.67M0.5%N/A0.417%
2/11/2021JBF Capital Inc.2,607$96K0.0%N/A0.060%
2/11/2021Northern Trust Corp8,707$0.32M0.0%N/A0.199%
2/11/2021Citigroup Inc.967$35K0.0%N/A0.022%
2/11/2021Dynamic Technology Lab Private Ltd13,202$0.48M0.1%N/A0.301%
2/10/2021Renaissance Technologies LLC254,423$9.33M0.0%-13.1%5.810%
2/9/2021Wells Fargo & Company MN1,552$57K0.0%+241.1%0.035%
2/5/2021BlackRock Inc.58,168$2.13M0.0%+166.8%1.328%
11/16/2020Worth Venture Partners LLC27,645$0.21M0.2%-21.8%0.667%
11/9/2020Acadian Asset Management LLC45,126$0.34M0.0%-2.5%1.396%
11/6/2020GSA Capital Partners LLP40,512$0.31M0.1%N/A1.253%
8/5/2020WINTON GROUP Ltd11,332$95K0.0%N/A0.351%
7/31/2020UBS Group AG10,015$83K0.0%-13.3%0.310%
5/1/2020BlackRock Inc.21,968$81K0.0%-92.8%0.679%
5/1/2020UBS Group AG11,548$43K0.0%-93.4%0.358%
2/14/2020Bank of New York Mellon Corp56,181$37K0.0%-44.2%0.124%
2/14/2020UBS Group AG175,092$0.12M0.0%+27.3%0.387%
2/13/2020Renaissance Technologies LLC2,379,859$1.56M0.0%+9.8%5.256%
(Data available from 1/1/2016 forward)













APVO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of APVO shares?

During the previous two years, 13 institutional investors and hedge funds held shares of Aptevo Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($1.41M), Sabby Management LLC ($0.44M), Armistice Capital LLC ($0.41M), Cantor Fitzgerald L. P. ($0.37M), Bank of New York Mellon Corp ($0.15M), Renaissance Technologies LLC ($0.12M), and Northern Trust Corp ($98K).Learn more on APVO's institutional investors.

What percentage of Aptevo Therapeutics stock is owned by institutional investors?

8.06% of Aptevo Therapeutics stock is owned by institutional investors. Learn more on APVO's institutional investor holdings.

Which institutional investors have been buying Aptevo Therapeutics stock?

Of the 10 institutional investors that purchased Aptevo Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Sabby Management LLC ($1.33M), Armistice Capital LLC ($1.24M), Citadel Advisors LLC ($0.28M), Cantor Fitzgerald L. P. ($0.17M), Renaissance Technologies LLC ($36.20K), Virtu Financial LLC ($28.42K), and Bank of New York Mellon Corp ($25.95K).

How much institutional buying is happening at Aptevo Therapeutics?

Institutional investors have bought a total of 3,143,806 shares in the last 24 months. This purchase volume represents approximately $1.87M in transactions.

Which Aptevo Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Aptevo Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($20.30K), Morgan Stanley ($7.50K), Northern Trust Corp ($5.87K), and Franklin Resources Inc. ($5.11K).

How much institutional selling is happening at Aptevo Therapeutics?

Institutional investors have sold a total of 38,782 shares in the last 24 months. This volume of shares sold represents approximately $0.15M in transactions.


This page (NASDAQ:APVO) was last updated on 3/1/2024 by MarketBeat.com Staff